KalVista Pharmaceuticals, Inc.
US Medical Excellence and Innovation Lead
KalVista Pharmaceuticals, Inc., Framingham, Massachusetts, us, 01704
US Medical Excellence and Innovation Lead
Join to apply for the US Medical Excellence and Innovation Lead role at KalVista Pharmaceuticals, Inc. About KalVista Pharmaceuticals, Inc.
KalVista is a global pharmaceutical company dedicated to delivering life‑changing oral therapies for individuals affected by rare diseases with significant unmet needs. The KalVista team discovered and developed EKTERLY®—the first and only oral on‑demand treatment for hereditary angioedema (HAE)—and continues to work closely with the global HAE community to improve treatment and care for this disease around the world. For more information about KalVista, please visit
www.kalvista.com
and follow us on LinkedIn, X, Facebook and Instagram. About EKTERLY® (sebetralstat)
EKTERLY (sebetralstat) is a novel plasma kallikrein inhibitor approved in the United States, European Union, United Kingdom and Switzerland for the treatment of acute attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is the first and only oral on‑demand treatment for HAE, offering efficacious and safe treatment of attacks without the burden of injections. With ongoing studies exploring its use in children aged two to 11 and multiple regulatory applications under review in key global markets, EKTERLY has the potential to become the foundational therapy for HAE management worldwide. About the Role
The role of the Medical Excellence and Innovation Lead will be to facilitate and implement KalVista’s medical strategic planning for the US, supporting medical operations and effective cross‑functional collaboration. The Medical Excellence and Innovation Lead will work closely with US Medical Affairs leadership and Medical field teams to ensure operational excellence and close cross‑functional collaboration, particularly in the development and refinement of systems and processes, trainings and events, KOL engagements, evidence generation, and the implementation of new technologies (e.g., artificial intelligence) to enhance the value of Medical Affairs. Responsibilities
Support the medical strategy and planning process and its implementation and execution in the US, including goal setting and budget management. Work with US Medical Affairs Leadership to drive development and execution of the US Medical Plan, Medical Training Programs and Events in collaboration with Global Medical Communications, HCP mapping and engagement plans to create operational transparency, MSL field activity planning and tracking, and Advisory Board contracting and logistical planning. Provide tactical support as goal tracking (including creating dashboards), coordinating meetings, maintaining medical education programs, communication hubs, vendor management and material review. Collaborate closely with Global Medical Operations to create operational transparency and identify opportunities for process improvements. Collect and curate insights and analytics from the field to assess appropriate KPIs to inform decision‑making. Collaborate with Medical Information to derive appropriate analytics to drive US Medical KPI and support US Medical insights. Lead the transformation of data, digital, and medical excellence initiatives to optimize medical initiatives’ performance and facilitate strategic decision‑making. Integrate new technologies, particularly artificial intelligence, to enhance research and personalize customer engagements. Drive the digital strategy and implementation efforts in US Medical Affairs, including initiatives such as artificial intelligence (AI), omni‑channel design, and other digital solutions. Qualifications
Master’s degree or higher (e.g., PhD, PharmD) in a relevant field, such as life sciences, business management, or health economics. Minimum of 5 years of experience in the pharma or biotech setting with 3+ years in Medical Affairs, MSL or Medical Operations experience is a plus. Fluency in English. Relevant therapeutic area knowledge in rare diseases; knowledge of hereditary angioedema a plus. Strong written and verbal communication skills, ability to present medical/scientific information in a clear and concise manner. Excellent organizational skills and results‑oriented mindset. Proven experience in medical affairs strategic planning, driving innovation strategy, and fostering data‑driven decision‑making in the pharmaceutical or healthcare sector. Strong business acumen and understanding of healthcare regulations and industry trends. Excellent communication, leadership, and project management skills. Ability to work and lead within the matrix of a dynamic, growing team. Framingham office‑based, minimum 3 days per week, 20% travel required. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran. Pay Range: $175,000—$220,000 USD
#J-18808-Ljbffr
Join to apply for the US Medical Excellence and Innovation Lead role at KalVista Pharmaceuticals, Inc. About KalVista Pharmaceuticals, Inc.
KalVista is a global pharmaceutical company dedicated to delivering life‑changing oral therapies for individuals affected by rare diseases with significant unmet needs. The KalVista team discovered and developed EKTERLY®—the first and only oral on‑demand treatment for hereditary angioedema (HAE)—and continues to work closely with the global HAE community to improve treatment and care for this disease around the world. For more information about KalVista, please visit
www.kalvista.com
and follow us on LinkedIn, X, Facebook and Instagram. About EKTERLY® (sebetralstat)
EKTERLY (sebetralstat) is a novel plasma kallikrein inhibitor approved in the United States, European Union, United Kingdom and Switzerland for the treatment of acute attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is the first and only oral on‑demand treatment for HAE, offering efficacious and safe treatment of attacks without the burden of injections. With ongoing studies exploring its use in children aged two to 11 and multiple regulatory applications under review in key global markets, EKTERLY has the potential to become the foundational therapy for HAE management worldwide. About the Role
The role of the Medical Excellence and Innovation Lead will be to facilitate and implement KalVista’s medical strategic planning for the US, supporting medical operations and effective cross‑functional collaboration. The Medical Excellence and Innovation Lead will work closely with US Medical Affairs leadership and Medical field teams to ensure operational excellence and close cross‑functional collaboration, particularly in the development and refinement of systems and processes, trainings and events, KOL engagements, evidence generation, and the implementation of new technologies (e.g., artificial intelligence) to enhance the value of Medical Affairs. Responsibilities
Support the medical strategy and planning process and its implementation and execution in the US, including goal setting and budget management. Work with US Medical Affairs Leadership to drive development and execution of the US Medical Plan, Medical Training Programs and Events in collaboration with Global Medical Communications, HCP mapping and engagement plans to create operational transparency, MSL field activity planning and tracking, and Advisory Board contracting and logistical planning. Provide tactical support as goal tracking (including creating dashboards), coordinating meetings, maintaining medical education programs, communication hubs, vendor management and material review. Collaborate closely with Global Medical Operations to create operational transparency and identify opportunities for process improvements. Collect and curate insights and analytics from the field to assess appropriate KPIs to inform decision‑making. Collaborate with Medical Information to derive appropriate analytics to drive US Medical KPI and support US Medical insights. Lead the transformation of data, digital, and medical excellence initiatives to optimize medical initiatives’ performance and facilitate strategic decision‑making. Integrate new technologies, particularly artificial intelligence, to enhance research and personalize customer engagements. Drive the digital strategy and implementation efforts in US Medical Affairs, including initiatives such as artificial intelligence (AI), omni‑channel design, and other digital solutions. Qualifications
Master’s degree or higher (e.g., PhD, PharmD) in a relevant field, such as life sciences, business management, or health economics. Minimum of 5 years of experience in the pharma or biotech setting with 3+ years in Medical Affairs, MSL or Medical Operations experience is a plus. Fluency in English. Relevant therapeutic area knowledge in rare diseases; knowledge of hereditary angioedema a plus. Strong written and verbal communication skills, ability to present medical/scientific information in a clear and concise manner. Excellent organizational skills and results‑oriented mindset. Proven experience in medical affairs strategic planning, driving innovation strategy, and fostering data‑driven decision‑making in the pharmaceutical or healthcare sector. Strong business acumen and understanding of healthcare regulations and industry trends. Excellent communication, leadership, and project management skills. Ability to work and lead within the matrix of a dynamic, growing team. Framingham office‑based, minimum 3 days per week, 20% travel required. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran. Pay Range: $175,000—$220,000 USD
#J-18808-Ljbffr